Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.1.17 (
ornithine decarboxylase
)
6,351
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Colony-stimulating factors (CSFs) stimulate the activation and steady-state mRNA accumulation of an important regulatory enzyme for macromolecular synthesis,
ornithine decarboxylase
(
ODC
). Cloned murine CSF-dependent cell lines exhibited a rapid activation of
ODC
enzyme activity, detectable within ten minutes of stimulations with either interleukin-3 (IL-3), GM-CSF, or G-CSF. This early phase of enzyme activation did not require early protein or mRNA synthesis. The subsequent protracted rise in
ODC
activity occurring four to six hours after CSF treatment was dependent on increases in steady-state
ODC
mRNA accumulation and de novo protein synthesis. CSF, therefore, modulates both posttranslational activation of preexisting
ODC
and stabilization and accumulation of
ODC
mRNA. Antiproliferative signals, such as cAMP or interferon-gamma (IFN-gamma), effectively inhibited the CSF-directed increase in steady-state
ODC
mRNA. Cotreatment of the murine
NSF
60.8 cell line with IFN-gamma and GM-CSF decreased steady-state
ODC
mRNA greater than 80% as compared with GM-CSF-treated cells alone. IFN treatment did not cause any appreciable destabilization of mature
ODC
mRNA, suggesting that its major effect may be at the level of
ODC
mRNA transcription or posttranscriptional processing. These data indicate that the
ODC
gene-protein system is an important molecular locus of the effects of myeloid proliferative and antiproliferation signals.
...
PMID:Myeloid growth factor(s) regulation of ornithine decarboxylase: effects of antiproliferative signals interferon-gamma and cAMP. 246 92